Skip to main content

Metilfenidat Reference Literatura Spoljašnje veze Мени за навигацијуMonografijaa682188Methylphenidate113-45-1WHO4158DB004224015207ZZ9QZ49D04999CHEBI:6887CHEMBL796When Was Ritalin Invented?The history of attention deficit hyperactivity disorder„F.D.A. Finds Short Supply of Attention Deficit Drugs”Архивирано„The impact of prescribed psychotropics on youth”21000411794950410.1186/1745-0179-3-21New Research Helps Explain Ritalin's Low Abuse Potential When Taken As Prescribed – 09/29/1998„The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes”146925510.1177/088307389200700420„Are we over medicating our kids? Speaking with Dr. Harold Koplewicz of @ChildMindDotOrg”оригиналаMetilfenidatDepartment of Energy September 29, 1998 press release on RitalinErowid methylphenidate vaultU.S. National Library of Medicine: Drug Information Portal – Methylphenidateуууsh91001552

3-PPP4-PPBP5-MeO-DMTAlazocin (SKF-10047)AmantadinANAVEX2-73ArketaminBD-737BD-1052KaptodiamCitalopramCGRPKloperastinKokainKutamezin (SA-4503)CiklazocinDehidroepiandrosteron (DHEA)prasteronDehidroepiandrosteron sulfat (DHEA-S)prasteron sulfatDekstralorfanDekstrometorfan (DXM)Dekstrorfan (DXO)DimemorfanDimetiltriptamin (DMT)Ditolilgvanidin (DTG)DonepezilEliprodilEscitalopramFabomotizol (afobazol)FluoksetinFluvoksaminIfenprodilIgmesin (JO-1784)IPABKetaminL-687384MDMA (midomafetamin)MemantinMetamfetaminMetoksetaminMetilfenidatNepinalonNeuropeptid YNoskapinOPC-14523OpipramolPentazocinPentoksiverin (karbetapentan)PRE-084PregnenolonPregnenolon sulfatPridopidinRacemetorfan (metorfan)Racemorfan (morfanol)UMB-23UMB-823-PPPAC-927BD-1008BD-1031BD-1047BD-1060BD-1063BD-1067BMY-14802 (BMS-181100)CM-156Dup-734E-5842E-52862 (S1RA)HaloperidolLR-132LR-172MS-377NE-100NPC-16377Panamesin (EMD-57455)PD-144418PentazocinProgesteronRimkazol (BW-234U)SertralinSR-31742AFenitoinMetilfenilpiracetamSOMCL-6683-Metoksidekstralorfan3-MeO-PCP4C-T-24-IBP4-IPBS4-MeO-PCP5-MeO-DALT5-MeO-DiPTAmitriptilinAzidopamilHlorpromazinKlemastinKlomipraminKlorgilinD-DeprenilDiPTDPTIbogainImipraminKCR-12-83.1NemonapridNoribogainRHL-033RS-67,333RTI-55ŠafranSafinamidSelegilinSpipetijanTrifluoperazinW-18YKP10ABerberinEtilketazocinForfitMetafitNalbufinNaluzotanTapentadolTenociklidinAHD1AZ66LamotriginNaloksonSM-21UMB-100UMB-101UMB-103UMB-116YZ-011YZ-069YZ-185SKF-8395918-MetoksikoronaridinBMY-13980ButaklamolKaramifenKarvotrolinHlorfenamin (hlorfeniramin)HlorpromazinCinarizinCinuperonKlocapraminDezocinEMD-59983HipericinkantarionFlufenazinGevotrolin (WY-47384)Mepiramin (pirilamin)MolindonPerfenazinPimozidProadifenPrometazinPropranololHinidinRemoksipridSL 82.0715SR-31747ATiospiron (BMY-13859)Venlafaksin


Карбоксилатни естриБиологија биполарног поремећајаМетил естриНоотропициИнхибитори норепинефрин-допаминског преузимањаПиперидиниСтимулантиСимпатомиметички аминиЕуфоријантиВазоконстрикториЛечење и управљање хиперкинетичким поремећајем


psihostimulišućileksupstituisani fenetilamintretmanhiperkinetičkog poremećajaposturalnog ortostatskog tahikardnog sindromanarkolepsijeCIBAFDA1955Metilfenidat










(function()var node=document.getElementById("mw-dismissablenotice-anonplace");if(node)node.outerHTML="u003Cdiv class="mw-dismissable-notice"u003Eu003Cdiv class="mw-dismissable-notice-close"u003E[u003Ca tabindex="0" role="button"u003Eсакријu003C/au003E]u003C/divu003Eu003Cdiv class="mw-dismissable-notice-body"u003Eu003Cdiv id="localNotice" lang="sr" dir="ltr"u003Eu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="https://meta.wikimedia.org/wiki/%D0%92%D0%B5%D0%BB%D0%B8%D0%BA%D0%BE_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%BD%D0%BE_%D1%81%D1%80%D0%B5%D1%92%D0%B8%D0%B2%D0%B0%D1%9A%D0%B5_%D0%9E%D1%81%D1%82%D0%B0%D0%B2%D0%B5" class="extiw" title="meta:Велико пролећно сређивање Оставе"u003Eu003Cspan style="color:white"u003EУчествуј у Великом пролећном сређивању Оставе од 15. марта до 15. априла!u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%A2%D0%B0%D0%BA%D0%BC%D0%B8%D1%87%D0%B5%D1%9A%D0%B5_%D1%83_%D0%BF%D0%B8%D1%81%D0%B0%D1%9A%D1%83_%D1%87%D0%BB%D0%B0%D0%BD%D0%B0%D0%BA%D0%B0/%D0%A6%D0%95%D0%95_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%B5_2019" title="Википедија:Такмичење у писању чланака/ЦЕЕ пролеће 2019"u003Eu003Cspan style="color:white"u003EТакмичи се у писању чланака о средњој и источној Европи од 21. марта до 31. маја!u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.2em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003EУ току је расправа о u003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D1%80%D0%B5%D0%B4%D0%BB%D0%BE%D0%B3/%D0%9F%D1%80%D0%B0%D0%B2%D0%BE_%D0%B0%D0%B4%D0%BC%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%82%D0%BE%D1%80_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D1%84%D0%B5%D1%98%D1%81%D0%B0" title="Википедија:Гласање/Предлог/Право администратор интерфејса"u003Eu003Cspan style="color:white"u003Eадминистраторима интерфејсаu003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.2em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003EУ току је гласање о u003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D0%BE%D0%B2%D0%B5%D1%9B%D0%B0%D1%9A%D0%B5_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%BE%D1%80%D0%B0_%D0%B7%D0%B0_%D1%81%D0%BB%D0%B8%D0%BA%D0%B5_%D0%BD%D0%B0_%D0%B3%D0%BB%D0%B0%D0%B2%D0%BD%D0%BE%D1%98_%D1%81%D1%82%D1%80%D0%B0%D0%BD%D0%B8" title="Википедија:Гласање/Повећање простора за слике на главној страни"u003Eu003Cspan style="color:white"u003Eповећању простора за слике на главној страниu003C/spanu003Eu003C/au003E и u003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D1%80%D0%B0%D0%B2%D0%B8%D0%BB%D0%B0_%D0%B7%D0%B0_%D0%BA%D0%BE%D1%80%D0%B8%D1%88%D1%9B%D0%B5%D1%9A%D0%B5_%D0%B8%D0%BC%D0%B5%D0%BD%D1%81%D0%BA%D0%BE%D0%B3_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%BE%D1%80%D0%B0_%D0%9D%D0%B0%D1%86%D1%80%D1%82" title="Википедија:Гласање/Правила за коришћење именског простора Нацрт"u003Eu003Cspan style="color:white"u003Eкоришћењу именског простора Нацртu003C/spanu003Eu003C/au003E.u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003E";());




Metilfenidat




Из Википедије, слободне енциклопедије






Иди на навигацију
Иди на претрагу




















































Metilfenidat (Concerta, Methylin, Ritalin, Equasym XL) je psihostimulišući lek i supstituisani fenetilamin koji je odobren tretman hiperkinetičkog poremećaja (ADHD), posturalnog ortostatskog tahikardnog sindroma i narkolepsije. Originalni patent je posedovalo preduzeće CIBA. FDA je odobrila ovaj lek 1955. za tretiranje hiperaktivnosti. Propisivan je od početka 1960-tih. Nivo proskripcija je znatno porastao tokom 1990-tih kad je ADHD dijagnoza postala šire prihvaćena.[1][2]



Reference




  1. ^ When Was Ritalin Invented?, citing Lawrence Diller: "Running on Ritalin", 1999


  2. ^ Lange, K.W. et al.: The history of attention deficit hyperactivity disorder. In: Attention Deficit Hyperactivity Disorders, 2(4):241-55. doi: 10.1007/s12402-010-0045-8.




Literatura



  • Gardiner Harris (3. 2. 2012). „F.D.A. Finds Short Supply of Attention Deficit Drugs”. The New York Times. Архивирано из оригинала на датум 03. 02. 2012. Приступљено 3. 2. 2012. »(Archived by WebCite® at [1])« 


  • Lakhan SE, Hagger-Johnson GE (2007). „The impact of prescribed psychotropics on youth”. Clin Pract Epidemol Ment Health. 3 (1): 21. PMC 2100041 Слободан приступ. PMID 17949504. doi:10.1186/1745-0179-3-21. 

  • Drug Enforcement Administration, Greene, S.H., Response to CHADD petition concerning Ritalin, 1995, August 7. Washington, DC: DEA, U.S. Department of Justice.


  • New Research Helps Explain Ritalin's Low Abuse Potential When Taken As Prescribed – 09/29/1998. Nih.gov. Retrieved on 2011-04-30.


  • Weinberg WA, Brumback RA (1992). „The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes”. J. Child Neurol. 7 (4): 431—45; discussion 446—61. PMID 1469255. doi:10.1177/088307389200700420. [мртва веза]


  • Presenters: Joan Hamburg and Dr. Harold Koplewicz (3. 2. 2012). „Are we over medicating our kids? Speaking with Dr. Harold Koplewicz of @ChildMindDotOrg”. Joan Hamburg Show (Radio). New York, NY. 1:11 into the complete two part show - 2 мин. WOR Radio Network. WOR. Архивирано из оригинала на датум 03. 12. 2012. Приступљено 10. 12. 2013. 


Spoljašnje veze


Mediji vezani za članak Metilfenidat na Vikimedijinoj ostavi



  • Metilfenidat на сајту DMOZ (на језику: енглески)


  • Department of Energy September 29, 1998 press release on Ritalin at Brookhaven National Laboratory

  • Erowid methylphenidate vault

  • U.S. National Library of Medicine: Drug Information Portal – Methylphenidate

Metilfenidat
Methylphenidate-2D-skeletal.svg
Methylphenidate3Dan.gif

IUPAC ime
metil fenil(piperidin-2-il)acetat
Klinički podaci
Prodajno imeConcerta, Methylin, Ritalin, Equasym XL
Drugs.comMonografija
MedlinePlusa682188
Podaci o licenci


  • US FDA: Methylphenidate

Kategorija trudnoće


  • AU: B3


  • US: C (Mogući rizik)


Opojna drogaModerate
Način primeneOralno, transdermalno
Pravni status
Pravni status


  • AU: S8 (Kontrolisana supst.)


  • CA: Schedule III


  • UK: Klasa B


  • US: Schedule II



Farmakokinetički podaci
Bioraspoloživost~30% (opseg: 11–52%)
Vezivanje proteina10-33%
Metabolizam
Hepatički (80%)
Poluvreme eliminacije3-4 sata (d-enantiomer), 1-3 sata (l-enantiomer)
Izlučivanje
Urin (90%)

Identifikatori
CAS broj
113-45-1 ДаY
ATC kod
N06BA04 (WHO)
PubChemCID 4158
DrugBank
DB00422 ДаY
ChemSpider
4015 ДаY
UNII
207ZZ9QZ49 ДаY
KEGG
D04999 ДаY
ChEBI
CHEBI:6887 ДаY
ChEMBL
CHEMBL796 ДаY
Hemijski podaci
Formula
C14H19NO2
Molarna masa233,30 g/mol



Fizički podaci
Tačka topljenja
214 °C (417 °F)


  • п

  • р

  • у


Adrenergici




























Преузето из „https://sr.wikipedia.org/w/index.php?title=Metilfenidat&oldid=20885905”










Мени за навигацију



























(window.RLQ=window.RLQ||[]).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"1.112","walltime":"1.376","ppvisitednodes":"value":6958,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":470901,"limit":2097152,"templateargumentsize":"value":52255,"limit":2097152,"expansiondepth":"value":25,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":1354,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 945.650 1 -total"," 37.43% 354.000 4 Шаблон:Infobox"," 36.06% 341.003 1 Шаблон:Drugbox-lat"," 16.82% 159.063 2 Шаблон:Navbox_with_collapsible_sections"," 10.18% 96.225 1 Шаблон:Dopaminergici-lat"," 9.89% 93.494 1 Шаблон:Мртва_веза"," 9.21% 87.063 14 Шаблон:Navbox_subgroup"," 8.99% 85.012 1 Шаблон:Fix"," 7.97% 75.342 1 Шаблон:Adrenergici-lat"," 7.89% 74.646 1 Шаблон:Commonscat-inline-lat"],"scribunto":"limitreport-timeusage":"value":"0.319","limit":"10.000","limitreport-memusage":"value":8330475,"limit":52428800,"cachereport":"origin":"mw1334","timestamp":"20190405191923","ttl":2592000,"transientcontent":false);mw.config.set("wgBackendResponseTime":119,"wgHostname":"mw1323"););
-

Popular posts from this blog

19. јануар Садржај Догађаји Рођења Смрти Празници и дани сећања Види још Референце Мени за навигацијуу

Image
1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.31.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30.1.2.3.4.5.6.7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28.29.30. ЈануарДани деветнаестиГрегоријанском календарупреступним годинама (function()var node=document.getElementById("mw-dismissabl...
Read more

Israel Cuprins Etimologie | Istorie | Geografie | Politică | Demografie | Educație | Economie | Cultură | Note explicative | Note bibliografice | Bibliografie | Legături externe | Meniu de navigaresite web oficialfacebooktweeterGoogle+Instagramcanal YouTubeInstagramtextmodificaremodificarewww.technion.ac.ilnew.huji.ac.ilwww.weizmann.ac.ilwww1.biu.ac.ilenglish.tau.ac.ilwww.haifa.ac.ilin.bgu.ac.ilwww.openu.ac.ilwww.ariel.ac.ilCIA FactbookHarta Israelului"Negotiating Jerusalem," Palestine–Israel JournalThe Schizoid Nature of Modern Hebrew: A Slavic Language in Search of a Semitic Past„Arabic in Israel: an official language and a cultural bridge”„Latest Population Statistics for Israel”„Israel Population”„Tables”„Report for Selected Countries and Subjects”Human Development Report 2016: Human Development for Everyone„Distribution of family income - Gini index”The World FactbookJerusalem Law„Israel”„Israel”„Zionist Leaders: David Ben-Gurion 1886–1973”„The status of Jerusalem”„Analysis: Kadima's big plans”„Israel's Hard-Learned Lessons”„The Legacy of Undefined Borders, Tel Aviv Notes No. 40, 5 iunie 2002”„Israel Journal: A Land Without Borders”„Population”„Israel closes decade with population of 7.5 million”Time Series-DataBank„Selected Statistics on Jerusalem Day 2007 (Hebrew)”Golan belongs to Syria, Druze protestGlobal Survey 2006: Middle East Progress Amid Global Gains in FreedomWHO: Life expectancy in Israel among highest in the worldInternational Monetary Fund, World Economic Outlook Database, April 2011: Nominal GDP list of countries. Data for the year 2010.„Israel's accession to the OECD”Popular Opinion„On the Move”Hosea 12:5„Walking the Bible Timeline”„Palestine: History”„Return to Zion”An invention called 'the Jewish people' – Haaretz – Israel NewsoriginalJewish and Non-Jewish Population of Palestine-Israel (1517–2004)ImmigrationJewishvirtuallibrary.orgChapter One: The Heralders of Zionism„The birth of modern Israel: A scrap of paper that changed history”„League of Nations: The Mandate for Palestine, 24 iulie 1922”The Population of Palestine Prior to 1948originalBackground Paper No. 47 (ST/DPI/SER.A/47)History: Foreign DominationTwo Hundred and Seventh Plenary Meeting„Israel (Labor Zionism)”Population, by Religion and Population GroupThe Suez CrisisAdolf EichmannJustice Ministry Reply to Amnesty International Report„The Interregnum”Israel Ministry of Foreign Affairs – The Palestinian National Covenant- July 1968Research on terrorism: trends, achievements & failuresThe Routledge Atlas of the Arab–Israeli conflict: The Complete History of the Struggle and the Efforts to Resolve It"George Habash, Palestinian Terrorism Tactician, Dies at 82."„1973: Arab states attack Israeli forces”Agranat Commission„Has Israel Annexed East Jerusalem?”original„After 4 Years, Intifada Still Smolders”From the End of the Cold War to 2001originalThe Oslo Accords, 1993Israel-PLO Recognition – Exchange of Letters between PM Rabin and Chairman Arafat – Sept 9- 1993Foundation for Middle East PeaceSources of Population Growth: Total Israeli Population and Settler Population, 1991–2003original„Israel marks Rabin assassination”The Wye River Memorandumoriginal„West Bank barrier route disputed, Israeli missile kills 2”"Permanent Ceasefire to Be Based on Creation Of Buffer Zone Free of Armed Personnel Other than UN, Lebanese Forces"„Hezbollah kills 8 soldiers, kidnaps two in offensive on northern border”„Olmert confirms peace talks with Syria”„Battleground Gaza: Israeli ground forces invade the strip”„IDF begins Gaza troop withdrawal, hours after ending 3-week offensive”„THE LAND: Geography and Climate”„Area of districts, sub-districts, natural regions and lakes”„Israel - Geography”„Makhteshim Country”Israel and the Palestinian Territories„Makhtesh Ramon”„The Living Dead Sea”„Temperatures reach record high in Pakistan”„Climate Extremes In Israel”Israel in figures„Deuteronom”„JNF: 240 million trees planted since 1901”„Vegetation of Israel and Neighboring Countries”Environmental Law in Israel„Executive branch”„Israel's election process explained”„The Electoral System in Israel”„Constitution for Israel”„All 120 incoming Knesset members”„Statul ISRAEL”„The Judiciary: The Court System”„Israel's high court unique in region”„Israel and the International Criminal Court: A Legal Battlefield”„Localities and population, by population group, district, sub-district and natural region”„Israel: Districts, Major Cities, Urban Localities & Metropolitan Areas”„Israel-Egypt Relations: Background & Overview of Peace Treaty”„Solana to Haaretz: New Rules of War Needed for Age of Terror”„Israel's Announcement Regarding Settlements”„United Nations Security Council Resolution 497”„Security Council resolution 478 (1980) on the status of Jerusalem”„Arabs will ask U.N. to seek razing of Israeli wall”„Olmert: Willing to trade land for peace”„Mapping Peace between Syria and Israel”„Egypt: Israel must accept the land-for-peace formula”„Israel: Age structure from 2005 to 2015”„Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition”10.1016/S0140-6736(15)61340-X„World Health Statistics 2014”„Life expectancy for Israeli men world's 4th highest”„Family Structure and Well-Being Across Israel's Diverse Population”„Fertility among Jewish and Muslim Women in Israel, by Level of Religiosity, 1979-2009”„Israel leaders in birth rate, but poverty major challenge”„Ethnic Groups”„Israel's population: Over 8.5 million”„Israel - Ethnic groups”„Jews, by country of origin and age”„Minority Communities in Israel: Background & Overview”„Israel”„Language in Israel”„Selected Data from the 2011 Social Survey on Mastery of the Hebrew Language and Usage of Languages”„Religions”„5 facts about Israeli Druze, a unique religious and ethnic group”„Israël”Israel Country Study Guide„Haredi city in Negev – blessing or curse?”„New town Harish harbors hopes of being more than another Pleasantville”„List of localities, in alphabetical order”„Muncitorii români, doriți în Israel”„Prietenia româno-israeliană la nevoie se cunoaște”„The Higher Education System in Israel”„Middle East”„Academic Ranking of World Universities 2016”„Israel”„Israel”„Jewish Nobel Prize Winners”„All Nobel Prizes in Literature”„All Nobel Peace Prizes”„All Prizes in Economic Sciences”„All Nobel Prizes in Chemistry”„List of Fields Medallists”„Sakharov Prize”„Țara care și-a sfidat "destinul" și se bate umăr la umăr cu Silicon Valley”„Apple's R&D center in Israel grew to about 800 employees”„Tim Cook: Apple's Herzliya R&D center second-largest in world”„Lecții de economie de la Israel”„Land use”Israel Investment and Business GuideA Country Study: IsraelCentral Bureau of StatisticsFlorin Diaconu, „Kadima: Flexibilitate și pragmatism, dar nici un compromis în chestiuni vitale", în Revista Institutului Diplomatic Român, anul I, numărul I, semestrul I, 2006, pp. 71-72Florin Diaconu, „Likud: Dreapta israeliană constant opusă retrocedării teritoriilor cureite prin luptă în 1967", în Revista Institutului Diplomatic Român, anul I, numărul I, semestrul I, 2006, pp. 73-74MassadaIsraelul a crescut in 50 de ani cât alte state intr-un mileniuIsrael Government PortalIsraelIsraelIsraelmmmmmXX451232cb118646298(data)4027808-634110000 0004 0372 0767n7900328503691455-bb46-37e3-91d2-cb064a35ffcc1003570400564274ge1294033523775214929302638955X146498911146498911

Image
Mentenanță CS1: Dată și anMentenanță CS1: Utilizare explicită a lui et al.IsraelȚări în Orientul MijlociuRepubliciSionismState membre ale Organizației Națiunilor Unite ebraicăarabărepublică parlamentarăOrientul MijlociuMării MediteraneLibanulSiriaIordaniaCisiordaniaEgiptFâșia GazaIerusalimTel AvivOrganizației Națiunilor Unite14 mai1948Mandatului britanic pentru PalestinaDavid Ben-GurionOrganizației SionisteAgenției Evreiești pentru PalestinaStatului IsraelONULiga ArabăpalestinieneRăzboiul arabo-israelian din 1948Conflict arabo-israelianTransiordaniaEgiptulRăzboiului de Șase ZileCisiordaniaPeninsula SinaiFâșia GazaÎnălțimile GolanBiroului Central de Statisticădruzicerchezisamariteniarmenidemocrație reprezentativăsistem parlamentarvot universalKnessetulgaze naturaleIndicelui Dezvoltării UmaneOCDEȚara I...
Read more

Кастелфранко ди Сопра Становништво Референце Спољашње везе Мени за навигацију43°37′18″ СГШ; 11°33′32″ ИГД / 43.62156° СГШ; 11.55885° ИГД / 43.62156; 11.5588543°37′18″ СГШ; 11°33′32″ ИГД / 43.62156° СГШ; 11.55885° ИГД / 43.62156; 11.558853179688„The GeoNames geographical database”„Istituto Nazionale di Statistica”проширитиууWorldCat156923403n850174324558639-1cb14643287r(подаци)

Image
Acquaborra-CaselleAdattiAlbergoAlberoroAmbraAnatraiaAnciolinaAnghiariAntriaAppaltoArea ProduttivaArezzoArsicciAvenaBaccanelloBadia A RuotiBadia AgnanoBadia PratagliaBadia TedaldaBadia TegaBadia al PinoBadicorteBadiola IBadiola IIBagnaiaBagnolo IBagnolo IIBanzenaBarbianoBarullo-CentoiaBatelliBattifolle-Ruscello-PoggiolaBattifolloBecarinoBeglianoBellavistaBellosguardoBertineBibbianoBibbienaBiccianoBiforcoBigurroBorgaccianoBorghettoBorgo alla CollinaBorgonuovoBorroBossi-CellaioBottegaBrancialinoBucineBugianaBuianoBulcianoBuon RiposoButaleCafaggioCaianoCalbuffaCalcinaiaCallagnoloCalletaCalucacciaCamaldoliCampaccioCampiCampogialliCampoleoneCampolombardoCampoluciCamprenaCamucia-MonsiglioloCapannoleCapezziCapolonaCaposelviCappella BrocchiCappuccini di MontautoCappucciniCapraiaCaprese MichelangeloCaprileCardaCardeta di SopraCarmineCasa BiondoCasa CaroniCasa MarcoCasa MugnainiCasa Vanni - le SelveCasa al CincioCasa alla SisaCasa del ReCasa le BizzeCasacciola-BelvedereCasal GoriCasaleCasalecchio...
Read more